Evidence map›Paper›PMID 31297379›Full record

ArticleAnnals of translational medicine2019

Clinical presentation, management and outcomes of sacral metastases: a multicenter, retrospective cohort study.

Raphaële Charest-Morin, Charles G Fisher, Ann L Versteeg, Arjun Sahgal, Peter Pal Varga, Daniel M Sciubba, James M Schuster, Michael H Weber, Michelle J Clarke, Laurence D Rhines and 6 more

Open access · diamondAbstract read
In one paragraph

Article in Annals of translational medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Finite element validation and short-term clinical outcomes of robot-assisted percutaneous microwave ablation plus cement augmentation and sacroiliac screw fixation for upper sacral (S1-S2) metastases.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Article
  2. Article
  3. Axial Axis Metastasis.Revista brasileira de ortopedia · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 12 institutions in 4 countries.

Raphaële Charest-MorinDepartment of Orthopaedics, Division of Spine, University of British Columbia and Vancouver General Hospital, Vancouver, BC, Canada.
Charles G FisherDepartment of Orthopaedics, Division of Spine, University of British Columbia and Vancouver General Hospital, Vancouver, BC, Canada.
Ann L VersteegDepartment of Orthopaedic Surgery, University Medical Center Utrecht, Utrecht, Netherlands.
Arjun SahgalDepartment of Radiation Oncology, University of Toronto, Toronto, ON, Canada.
Peter Pal VargaNational Center for Spinal Disorders and Buda Health Center, Budapest, Hungary.
Daniel M SciubbaDepartment of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
James M SchusterDepartment of Neurosurgery, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Michael H WeberDepartment of Orthopaedic Surgery, McGill University, Montreal, Qc, Canada.
Michelle J ClarkeDepartment of Neurosurgery, Mayo Clinic, Rochester, MN, USA.
Laurence D RhinesDepartment of Neurosurgery, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA.
Stefano BorianiIRCCS Galeazzi Orthopedic Inst, Milan, Italy.
Chetan BettegowdaDepartment of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Michael G FehlingsDepartment of Surgery, Division of Neurosurgery and Spinal Program, University of Toronto and Toronto Western Hospital, Toronto, ON, Canada.
Paul M ArnoldDepartment of Neurosurgery, University of Kansas Medical Center, Kansas City, KS, USA.
Ziya L GokaslanDepartment of Neurosurgery, Rhode Island Hospital, The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Nicolas DeaDepartment of Orthopaedics, Division of Spine, University of British Columbia and Vancouver General Hospital, Vancouver, BC, Canada.
Vancouver General Hospital · CAJohns Hopkins Medicine · USUniversity of British Columbia · CABrown University · USBuda Health Center · HUHospital of the University of Pennsylvania · USMayo Clinic in Arizona · USMcGill University · CAThe University of Texas MD Anderson Cancer Center · USUniversity Medical Center Utrecht · NLUniversity of Kansas Medical Center · USUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSacral metastases are rare and literature regarding their management is sparse. This multicenter, prospective, observational study aimed to determine health related-quality of life (HRQOL) and pain in patients treated for sacral metastases with surgery and/or radiation therapy (RT). The secondary objectives were to describe the adverse event (AE) profile and change in neurologic function in this population.

methodsTwenty-three patients presenting with symptomatic sacral metastases were identified from the Epidemiology, Process and Outcomes of Spine Oncology (EPOSO) dataset, a prospective multicenter study on spinal metastases. Patients requiring surgery and/or RT between August 2013 and February 2017 were prospectively enrolled. HRQOL, assessed by the Spine Oncology Study Group Outcomes Questionnaire (SOSGOQv2.0), the Short Form-36 version 2 (SF-36v2), and the EuroQol-5Dimension (EQ-5D) was documented at baseline, 6 weeks, 3 and 6 months post-treatment. Pain numeric rating scale (NRS), AEs, lower extremities motor score (ASIA), and bowel and bladder function were also recorded.

resultsEight patients underwent surgery ± RT and 15 patients underwent RT alone. Mean age was 59.3 (SD 11.7) years and 13 patients were female. At 6 months, 3 (37.5%) surgical patients and 2 (13.3%) RT patients were deceased. There was a trend showing that surgical patients had worse baseline HRQOL and pain. Pain NRS, EQ-5D, SOSGOQv2.0, and the mental component of the SF-36v2 showed improvement, irrespective of treatment (P>0.05). Ten AEs occurred in the surgical cohort, dominated by wound complications (n=3). Bowel and bladder function improved at 6 weeks in both groups.

conclusionsSurgical treatment and RT are both valid treatment options for symptomatic sacral metastases. Improvement in HRQOL can be expected with an acceptable AE rate.

Indexed as

adverse events (AEs)health related-quality-of-life (HRQOL)radiation therapy (RT)Sacral metastasessurgery

Identifiers

PMID31297379
PMCPMC6595205
OpenAlexW2944041948

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.